Over 24 hours, 500.12 billion Shiba Inu tokens were transferred to exchanges, but withdrawals exceeded deposits, resulting in a net outflow. This suggests less immediate selling pressure despite the large gross inflow. The SHIB price traded around 5.76 millionths of a dollar, holding above its 200-day moving average and approaching resistance at 6.0 to 6.2 millionths. Meanwhile, the token burn rate dropped sharply, indicating limited impact on supply reduction. Investors should watch net flows and price levels for future direction, while considering tax implications and custody options for longer-term holdings.
Shiba Inu token activity is reported here with Pluang market data as of Sep 30, 2026 04:03 WIB. Among 50 major cryptocurrencies priced on Pluang, 29 rose and 20 fell today. Notable movers include SNX at Rp4.589 with a 5.18% gain and a typical hold time of 70 days, KSM at Rp85.674 up 4.89% with 94% sell order activity, and COMP at Rp442.379 rising 4.62% with a nearly balanced buy/sell split. The most notable figure is SNX's 99% buy order activity, indicating strong buying interest.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
